Watson Pharmaceuticals, Inc. (NYSE:WPI)

CAPS Rating: 4 out of 5

The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.

Recs

0
Player Avatar lting77 (64.58) Submitted: 10/31/2010 9:26:22 PM : Outperform Start Price: $46.85 WPI Score: +44.17

with the purchase of arrow group, is has acquire first to market atorvastatin and partial ownership of eden biodesign, bio generic firm

would not be surprise if teva acquires them after it's done w/ digesting ratiopharm

Report this Post Reply

Featured Broker Partners


Advertisement